SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-280582
Filing Date
2019-10-31
Accepted
2019-10-31 17:05:13
Documents
15
Period of Report
2019-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d816951d8k.htm   iXBRL 8-K 53753
2 EX-99.1 d816951dex991.htm EX-99.1 25029
7 GRAPHIC g816951001.jpg GRAPHIC 5894
  Complete submission text file 0001193125-19-280582.txt   263682

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20191031.xsd EX-101.SCH 4548
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20191031_def.xml EX-101.DEF 13774
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20191031_lab.xml EX-101.LAB 22822
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20191031_pre.xml EX-101.PRE 14743
15 EXTRACTED XBRL INSTANCE DOCUMENT d816951d8k_htm.xml XML 6351
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 191184409
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences